COVID-19, Influenza A, Metapneumovirus, Respiratory syncytial virus Infection, Respiratory viral disease
Conditions
Interventions
None listed
Sponsors
NextCell Pharma AB
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Countries
Sweden
Outcome results
None listed